Company intelligence

SonoThera

Biotech

Suggest a correction

Recent changes

Jun 30, 2026Jun 30, 2026Raised $125.5M SEC EDGAR Form D
Jun 10, 2026Jun 10, 2026SonoThera Raises $125M for Ultrasound Gene Therapy Pulse story

Funding History

1 event · sources dated per row

Date	Event	Amount	Valuation	Investors	Source
Jun 30, 2026	funding round	$125.5M	—		SEC EDGAR Form D

Investors

ARCH Venture Partners

Latest Pulse

Jun 10, 2026SonoThera Raises $125M for Ultrasound Gene TherapySonoThera closed an oversubscribed $125 million Series B led by Vida Ventures to push its ultrasound-delivered, nonviral genetic medicine platform toward its first clinical trial in Duchenne muscular dystrophy in 2027.→

Coverage Timeline

newest first

Jun 10, 2026FUNDINGSonoThera Raises $125M for Ultrasound Gene Therapy$125M Series B→

All Coverage

FUNDING· Jun 10, 2026

SonoThera Raises $125M for Ultrasound Gene Therapy

Illustration for: SonoThera Raises $125M for Ultrasound Gene Therapy

FUNDING$125M Series B

SonoThera Raises $125M for Ultrasound Gene Therapy

SonoThera closed an oversubscribed $125 million Series B led by Vida Ventures to push its ultrasound-delivered, nonviral genetic medicine platform toward its first clinical trial in Duchenne muscular dystrophy in 2027.

Related Companies

Same sector

Attovia Therapeutics Apnimed Braveheart Bio Latigo Biotherapeutics Scribe Therapeutics

Sources & methodologyshow

Where these figures come from

SEC EDGAR Form Dprimary source1 fact

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction